| Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|
| Revenue | ||||
| Cost of revenue | ||||
| Operating income | ||||
| Operating margin | ||||
| Net income | ||||
| Net profit margin | ||||
| Cash on hand | ||||
| Change in cash | ||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 88.32 mm | 88.32 mm | 88.32 mm | 88.32 mm | 88.32 mm | 88.32 mm |
| Cash burn (monthly) | 8.44 mm | 9.26 mm | 11.35 mm | 12.61 mm | 8.41 mm | 9.39 mm |
| Cash used (since last report) | 42.75 mm | 46.89 mm | 57.44 mm | 63.84 mm | 42.55 mm | 47.56 mm |
| Cash remaining | 45.57 mm | 41.43 mm | 30.88 mm | 24.48 mm | 45.77 mm | 40.76 mm |
| Runway (months of cash) | 5.4 | 4.5 | 2.7 | 1.9 | 5.4 | 4.3 |
| 13F holders | Current |
|---|---|
| Total holders | 116 |
| Opened positions | 33 |
| Closed positions | 11 |
| Increased positions | 28 |
| Reduced positions | 27 |
| 13F shares | Current |
|---|---|
| Total value | 88.26 bn |
| Total shares | 27.46 mm |
| Total puts | 1.08 mm |
| Total calls | 1.80 mm |
| Total put/call ratio | 0.6 |
| Largest owners | Shares | Value |
|---|---|---|
| FMR | 5.44 mm | $21.09 bn |
| Cormorant Asset Management | 3.57 mm | $13.85 bn |
| Cormorant Global Healthcare Master Fund | 3.57 mm | $114.09 mm |
| BlackRock | 2.22 mm | $8.61 bn |
| Baker Bros. Advisors | 1.45 mm | $5.63 bn |
| Vanguard | 1.40 mm | $5.44 bn |
| Aisling Capital Management | 798.76 k | $3.10 bn |
| STT State Street | 604.36 k | $2.34 bn |
| Geode Capital Management | 604.15 k | $2.34 bn |
| Two Sigma Investments | 559.93 k | $2.17 bn |
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Nov 24 | Franco Valle | Common Stock | Grant | Acquire A | No | No | 6.154 | 495 | 3.05 k | 42,995 |
| 30 Sep 24 | Michael J.M. Hitchcock | Common Stock | Buy | Acquire P | No | No | 10.06 | 10,000 | 100.60 k | 15,000 |
| 12 Jun 24 | Chen Bihua | Stock Option Common Stock | Grant | Acquire A | No | No | 4.63 | 51,025 | 236.25 k | 51.025 |
| 12 Jun 24 | Sumita Ray | Stock Option Common Stock | Grant | Acquire A | No | No | 4.63 | 51,025 | 236.25 k | 51,025 |
| 12 Jun 24 | Michael J.M. Hitchcock | Stock Option Common Stock | Grant | Acquire A | No | No | 4.63 | 51,025 | 236.25 k | 51,025 |
